Wockhardt Slapped With U.S. Ban on Third Drug-Making Factory

A third Wockhardt Ltd. drug-manufacturing plant in India has been banned by the Food and Drug Administration from importing products into the U.S., the agency said Aug. 5.

The FDA said in an alert posted online that it had banned all drugs and drug products made by the factory. The plant, based in Ankleshwar, India, makes bulk ingredients, according to Wockhardt’s annual report. The agency recently inspected the Ankleshwar facility and three others, the company said in the report, and Wockhardt had responded to those findings.

Details of the FDA’s observations haven’t been made public, and Lyndsay Meyer, a spokeswoman for the ...